Hodgkin's lymphoma epidemiology and demographics
|
Hodgkin's lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hodgkin's lymphoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Hodgkin's lymphoma epidemiology and demographics |
|
Hodgkin's lymphoma epidemiology and demographics in the news |
|
Risk calculators and risk factors for Hodgkin's lymphoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Overview
Unlike some other lymphomas, whose incidence increases with age, Hodgkin's lymphoma has a bimodal incidence curve; that is, it occurs most frequently in two separate age groups, the first being young adulthood (age 15–35) and the second being in those over 55 years old although these peaks may vary slightly with nationality.[1] Overall, it is more common in men, except for the nodular sclerosis variant (see below), which is more common in women.
The annual incidence of Hodgkin's lymphoma is about 1/25,000 people, and the disease accounts for slightly less than 1% of all cancers worldwide.
The incidence of Hodgkin's lymphoma is increased in patients with HIV infection.[2] In contrast to many other lymphomas associated with HIV infection it occurs most commonly in patients with higher CD4 T cell counts.
Epidemiology and Demographics
Prevalence
- In the United States, the [age adjusted] prevalence of (insert disease name here) is _____ % in 2011.[3]
Incidence
- The delay-adjusted incidence of (insert disease name here) in 2011 was estimated to be _____ per 100,000 persons in the United States.[3]
- In 2011, the age-adjusted incidence of (insert disease name here) was _____ per 100,000 persons in the United States.[3]
Age
- While the overall age adjusted incidence of (insert disease name here) in the United States between YEAR and YEAR is _____ per 100,000, the age-adjusted incidence of (insert disease name here) by age category is:[3]
- Under 65 years: _____ per 100,000
- 65 and over: _____ per 100,000
Gender
- In the United States, the [age adjusted] prevalence of (insert disease name here) by gender in 2011 is:[3]
- In males: _____ %
- In females: _____ %
- In the United States, the delay-adjusted incidence of (insert disease name here) by gender in 2011 is:[3]
- In males: _____ per 100,000 persons
- In females: _____ per 100,000 persons
- In the United States, the age-adjusted incidence of (insert disease name here) by gender on 2011 is:[3]
- In males: _____ per 100,000 persons
- In females: _____ per 100,000 persons
Shown below is an image depicting the delay-adjusted incidence and observed incidence of invasive esophageal cancer by gender and race in the United States between YEAR and YEAR. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.[3]
[Insert figure x.1 from the report]
Race
- Shown below is a table depicting the [age adjusted] prevalence of (insert disease name here) by race in 2011 in the United States.[3]
| All Races | White | Black | Asian/Pacific Islander | American Indian/Alaska Native | Hispanic | |
| Age-adjusted prevalence |
- In the United States, the race that is most susceptible to developing this disease/condition, is the ____ race.[3]
Shown below is an image depicting the incidence of (insert disease name here) by race in the United States between YEAR and YEAR.[3]
[Insert figure x.2 from the report]
Percent Distribution of (insert disease name here) by Histology
- Among patients with histologically confirmed cases of (insert disease name here), the percent distribution of the types of the disease between YEAR and YEAR in the United States are:[3]
- Type X: _____ %
- Type Y: _____ %
- Type Z: _____ %
References
- ↑ Mauch, Peter (1999). Hodgkin's Disease. Lippincott Williams & Wilkins. pp. 62–64. ISBN 0-7817-1502-4. Unknown parameter
|coauthors=ignored (help) - ↑ Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA (2006). "Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS". Blood. 108 (12): 3786–91. doi:10.1182/blood-2006-05-024109. PMID 16917006.
- ↑ 3.00 3.01 3.02 3.03 3.04 3.05 3.06 3.07 3.08 3.09 3.10 3.11 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.